Results 191 to 200 of about 211,779 (381)

HYPNOTIC EFFECT OF 8-CHLORO-6-PHENYL-4H-S-TRIAZOLO [4,3-a] [1, 4] BENZODIAZEPINE (D-40TA) IN EXPERIMENTALLY INDUCED INSOMNIA AND BRAIN SEROTONIN IN RATS

, 1973
Hitoshi Ikeda, Yomei TAKE, YUMIKO ITOH, Yuji Nagawa   +3 more
openalex   +1 more source

Formulating Cognitive Functioning to Guide Personalised Treatment for People Diagnosed With Mental Disorders

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Objective and subjective cognitive impairment are highly prevalent in mental disorders and transdiagnostic phenomena. Cognitive impairment is associated with poorer functional outcomes and therefore requires treatment, but little guidance is available for clinicians.
Kelly Allott, Shayden Bryce, Katie Douglas, Alexandra Stainton, Stephen J. Wood, Christopher R. Bowie   +5 more
wiley   +1 more source

The Incidence of Benzodiazepine and Benzodiazepine-Related Drug Use in People With and Without Parkinson's Disease-A Nationwide Cohort Study. [PDF]

Basic Clin Pharmacol Toxicol
Lonka V, Hartikainen S, Tiihonen M, Koponen M, Tolppanen AM.   +4 more
europepmc   +1 more source

Ring Expansion Reaction of 4-Quinazolinones to 1,4-Benzodiazepines

, 1974
Yoshihisa Yamada, Toyonari Oine, Ichizo Inoue   +2 more
openalex   +1 more source

Positive feedback effect of benzodiazepine alkaloids on enzymes of the aromatic pathway [PDF]

, 1989
Werner Roos, H.‐P. Schmauder
openalex   +1 more source

Neural Correlates of Cognitive Improvement After Virtual Reality‐Based Cognitive Remediation in Psychosis and Mood Disorders: A Randomized Controlled Trial

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Cognitive impairment in mood disorders and schizophrenia spectrum disorders hampers patients' clinical and functional outcomes. A key challenge in pro‐cognitive treatment development is the limited insight into the underlying neurocircuitry correlates of cognitive changes.
Viktoria Damgaard, Andreas Elleby Jespersen, Ida Kruse Søndergaard, Anders Lumbye, Maj Vinberg, Louise Birkedal Glenthøj, Merete Nordentoft, Anjali Sankar, Gitte Moos Knudsen, Julian Macoveanu, Kamilla Woznica Miskowiak   +10 more
wiley   +1 more source

Harm reduction approaches for the use of benzodiazepines: a scoping review. [PDF]

Harm Reduct J
Morrison C, Natale I, Branchflower A, Harvey C, Lundin RM.   +4 more
europepmc   +1 more source

Psychogenic Urinary Frequency and the Role of Kampo Medicine: Addressing Limitations of SSRI Therapy in Panic Disorder

Traditional &Kampo Medicine, EarlyView.
Kazuyoshi Johnin, Yuri Mori, Kenichi Kobayashi, Tetsuya Yoshida, Susumu Kageyama   +4 more
wiley   +1 more source

Efficacy and Acceptability of Licensed and Off‐Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta‐Analysis of Randomised Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background A wide range of drugs is used to alleviate insomnia symptoms in individuals with severe mental illness (SMI), including licensed drugs and sedating drugs prescribed off‐label. Yet, no review has gathered the evidence on illness‐specific or transdiagnostic outcomes of pharmacological interventions for insomnia.
Nina Friis Bak Fuglsang, Nanna Marker Madsen, Søren Lundorff Jacobsen, Julie Eg Frøkjær, Nicolai Ladegaard, Marc Alberg Sørensen, Christoph U. Correll, Christian Otte, Mikkel Højlund, Ole Köhler‐Forsberg   +9 more
wiley   +1 more source

Assessment of benzodiazepine dosing in status epilepticus patients in the emergency department. [PDF]

Front Neurol
Aljadeed RI, Alkaf A, Alhajlbrahim D, Alewairdhi H, Assiri GA, Aljadeed R, Almalag H, Kalagi N.   +7 more
europepmc   +1 more source